Informação sobre produto
- Eluxadoline
- 5-[[[(2S)-2-Amino-3-[4-(aminocarbonyl)-2,6-dimethylphenyl]-1-oxopropyl][(1S)-1-(5-phenyl-1H-imidazol-2-yl)ethyl]amino]methyl]-2-methoxybenzoic acid
- Benzoic acid, 5-[[[(2S)-2-amino-3-[4-(aminocarbonyl)-2,6-dimethylphenyl]-1-oxopropyl][(1S)-1-(4-phenyl-1H-imidazol-2-yl)ethyl]amino]methyl]-2-methoxy-
- JNJ 27018966
- Benzoic acid, 5-[[[(2S)-2-amino-3-[4-(aminocarbonyl)-2,6-dimethylphenyl]-1-oxopropyl][(1S)-1-(5-phenyl-1H-imidazol-2-yl)ethyl]amino]methyl]-2-methoxy-
Eluxadoline is a drug that has been developed to treat the symptoms of irritable bowel syndrome with constipation. This medicine is a selective agonist at opioid receptors, which are found in the bowel and the central nervous system. Eluxadoline has demonstrated efficacy in patients with inflammatory bowel diseases, including ulcerative colitis, Crohn's disease, and pouchitis. The drug is not metabolized by cytochrome P450 enzymes and does not inhibit or induce these enzymes. It also does not bind to serum proteins such as albumin or α1-acid glycoprotein. Side effects can include nausea, dizziness, headache, and diarrhea.
Propriedades químicas
Consulta técnica sobre: 3D-FE146108 Eluxadoline deuterated
Se desejar solicitar um orçamento ou fazer uma encomenda, por favor, adicione os produtos ao seu carrinho e depois solicite um orçamento ou encomenda a partir do carrinho. É mais rápido, mais barato e poderá beneficiar-se dos descontos e outras vantagens disponíveis.
